FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167786767> ?p ?o ?g. }

• W3167786767 endingPage "237" @default.
• W3167786767 startingPage "237" @default.
• W3167786767 abstract "237 Purpose: The metabolic activity of tumor can be assessed by 18F-fluorodeoxyglucose positron emission tomography (FDG PET). High FDG tumor uptake is associated with worse prognosis in patients with non small cell lung cancer (NSCLC). On the other hand, high immune cell infiltration in primary tumor has been linked to better prognosis in NSCLC. Considering these contrary prognostic impacts, the prognostic value of tumor FDG uptake may be confounded by the infiltrating immune cells, because tumor FDG uptake is indistinguishable between cancer cells and infiltrating immune cells. Thus, we hypothesized that prognosis of the patients with lung adenocarcinoma can be further stratified by integration of FDG PET parameters and infiltrating immune cell scores assessed by genomic analysis. Methods: We obtained transcriptomic data, FDG PET data, and clinical data from 96 lung adenocarcinoma patients from ‘NSCLC-radiogenomics’ data set in the cancer imaging archive. The patients were divided into three subtypes, terminal respiratory unit (TRU), proximal proliferative (PP), and proximal inflammatory (PI) using RNA sequencing data [1]. In addition, maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and coefficient of variation (COV) were obtained through primary tumor segmentation. To normalize FDG uptake of tumor, tumor-to-liver uptake ratio with SUVmax (TLR) was calculated using FDG uptake of liver in each patients. For quantification of infiltrating immune cell, Bindea signatures for 24 immune cells, immune score and cytolytic score (CYT) were obtained from RNA sequencing data [2, 3]. Immune score was obtained using xCell and CYT was calculated as the geometric mean of PRF1 and GZMA gene expression. ANOVA test, Chi-square test and correlation analysis were conducted to determine the differences between the subtypes (Figure 1). Kaplan-meier survival analysis with log-rank test was done after the FDG PET and immune cell parameters were divided into low and high groups. Results: Sex distribution, stage, immune signatures, TLR and COV were significantly different (P = .004, .002, .001, .038 and .001) according to the subtypes (Table S1). In particular, it was found that the TRU had lower FDG PET parameters, a larger portion of female, and lower stage than the other subtypes. Meanwhile, PI group showed significantly higher immune score and CYT (P = 0.001, 0.001). Although FDG PET and immune cell parameters showed no association, in a subgroup analysis, PI group showed weak positive correlation (Figure S1). This finding is probably due to higher immune cell infiltration in PI group than the other groups. In assessment of prognostic values of the FDG PET parameters, high TLR (median as a cut-off = 1.51, P = .01) and high COV (median as a cut-off = 0.25, P = .04) were associated with worse prognosis. Also, among immune cell related scores, low CYT (median as a cut-off = 2.722, P = .05), high CD8 T cell (median as a cut-off = 0.0472, P = .036), and high T follicular helper cell (TFH) (median as a cut-off = 0.12, P = .005) were found to be associated with better prognosis (Figure S2). Furthermore, TLR and TFH were predictive of prognosis even after adjusting for clinicopathologic features and the other (P = .024 and .047) (Table S2). Survival analysis for four groups divided by TLR and TFH using median as cut offs showed prognostic value (P = .002) (Figure S3). Conclusions: High TLR was associated with worse prognosis while high scores of CD8 T cell and TFH predicted better prognosis in lung adenocarcinoma. Furthermore, TLR and TFH could predict prognosis independently and the combination of the two parameters could further stratify the prognosis of the patients with lung adenocarcinoma. This finding suggests that the integrative analysis of tumor FDG uptake and infiltrating immune cell based on genomic analysis would provide better prognostic biomarker than using single modality in cancer patients." @default.
• W3167786767 created "2021-06-22" @default.
• W3167786767 creator A5008413778 @default.
• W3167786767 creator A5057036329 @default.
• W3167786767 creator A5067428277 @default.
• W3167786767 date "2020-05-01" @default.
• W3167786767 modified "2023-09-24" @default.
• W3167786767 title "Prognostic impact of integrative analysis between FDG PET parameters and infiltrating immune cells in lung adenocarcinoma" @default.
• W3167786767 hasPublicationYear "2020" @default.
• W3167786767 type Work @default.
• W3167786767 sameAs 3167786767 @default.
• W3167786767 citedByCount "0" @default.
• W3167786767 crossrefType "journal-article" @default.
• W3167786767 hasAuthorship W3167786767A5008413778 @default.
• W3167786767 hasAuthorship W3167786767A5057036329 @default.
• W3167786767 hasAuthorship W3167786767A5067428277 @default.
• W3167786767 hasConcept C121608353 @default.
• W3167786767 hasConcept C126322002 @default.
• W3167786767 hasConcept C126838900 @default.
• W3167786767 hasConcept C142724271 @default.
• W3167786767 hasConcept C143998085 @default.
• W3167786767 hasConcept C163500349 @default.
• W3167786767 hasConcept C199374082 @default.
• W3167786767 hasConcept C203014093 @default.
• W3167786767 hasConcept C2775842073 @default.
• W3167786767 hasConcept C2776256026 @default.
• W3167786767 hasConcept C2778559731 @default.
• W3167786767 hasConcept C2781182431 @default.
• W3167786767 hasConcept C2989005 @default.
• W3167786767 hasConcept C502942594 @default.
• W3167786767 hasConcept C71924100 @default.
• W3167786767 hasConcept C8891405 @default.
• W3167786767 hasConceptScore W3167786767C121608353 @default.
• W3167786767 hasConceptScore W3167786767C126322002 @default.
• W3167786767 hasConceptScore W3167786767C126838900 @default.
• W3167786767 hasConceptScore W3167786767C142724271 @default.
• W3167786767 hasConceptScore W3167786767C143998085 @default.
• W3167786767 hasConceptScore W3167786767C163500349 @default.
• W3167786767 hasConceptScore W3167786767C199374082 @default.
• W3167786767 hasConceptScore W3167786767C203014093 @default.
• W3167786767 hasConceptScore W3167786767C2775842073 @default.
• W3167786767 hasConceptScore W3167786767C2776256026 @default.
• W3167786767 hasConceptScore W3167786767C2778559731 @default.
• W3167786767 hasConceptScore W3167786767C2781182431 @default.
• W3167786767 hasConceptScore W3167786767C2989005 @default.
• W3167786767 hasConceptScore W3167786767C502942594 @default.
• W3167786767 hasConceptScore W3167786767C71924100 @default.
• W3167786767 hasConceptScore W3167786767C8891405 @default.
• W3167786767 hasLocation W31677867671 @default.
• W3167786767 hasOpenAccess W3167786767 @default.
• W3167786767 hasPrimaryLocation W31677867671 @default.
• W3167786767 hasRelatedWork W1999604466 @default.
• W3167786767 hasRelatedWork W2060380495 @default.
• W3167786767 hasRelatedWork W2156892560 @default.
• W3167786767 hasRelatedWork W2229143684 @default.
• W3167786767 hasRelatedWork W2385139426 @default.
• W3167786767 hasRelatedWork W2560574327 @default.
• W3167786767 hasRelatedWork W2605534827 @default.
• W3167786767 hasRelatedWork W2618327597 @default.
• W3167786767 hasRelatedWork W2775777048 @default.
• W3167786767 hasRelatedWork W2784644666 @default.
• W3167786767 hasRelatedWork W2790132093 @default.
• W3167786767 hasRelatedWork W2972555250 @default.
• W3167786767 hasRelatedWork W2979898878 @default.
• W3167786767 hasRelatedWork W2983211431 @default.
• W3167786767 hasRelatedWork W3014415511 @default.
• W3167786767 hasRelatedWork W3027988953 @default.
• W3167786767 hasRelatedWork W3092546363 @default.
• W3167786767 hasRelatedWork W3172126053 @default.
• W3167786767 hasRelatedWork W3190542965 @default.
• W3167786767 hasRelatedWork W3198243480 @default.
• W3167786767 hasVolume "61" @default.
• W3167786767 isParatext "false" @default.
• W3167786767 isRetracted "false" @default.
• W3167786767 magId "3167786767" @default.
• W3167786767 workType "article" @default.